Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (27)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Rose, M. L.
Right arrow Articles by Thurman, R. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rose, M. L.
Right arrow Articles by Thurman, R. G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol. 20, No. 5, 793-798, May 1999
© 1999 Oxford University Press

Dietary glycine inhibits the growth of B16 melanoma tumors in mice

Michelle L. Rose1,2, Johnathan Madren2, Hartwig Bunzendahl3 and Ronald G. Thurman1,2,4

1 Curriculum in Toxicology, Laboratory of Hepatobiology and Toxicology,
2 Department of Pharmacology and
3 Department of Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7365, USA

Dietary glycine inhibited hepatocyte proliferation in response to the carcinogen WY-14,643. Since increased cell replication is associated with hepatic cancer caused by WY-14,643, glycine may have anti-cancer properties. Therefore, these experiments were designed to test the hypothesis that dietary glycine would inhibit the growth of tumors arising from B16 melanoma cells implanted subcutaneously in mice. C57BL/6 mice were fed diet supplemented with 5% glycine and 15% casein or control diet (20% casein) for 3 days prior to subcutaneous implantation of B16 tumor cells. Tumor volume was estimated from tumor diameter for 14 days. Tumors were excised, weighed and sectioned for histology post-mortem. B16 cells and endothelial cells were cultured in vitro to assess effects of glycine on cell growth. Statistical tests were two-sided and a P-value of 0.05 was defined as a significant difference between groups. Weight gain did not differ between mice fed control and glycine-containing diets. B16 tumors grew rapidly in mice fed control diet; however, in mice fed glycine diet, tumor size was 50–75% less. At the time of death, tumors from glycine-fed mice weighed nearly 65% less than tumors from mice fed control diet (P < 0.05). Glycine (0.01–10 mM) did not effect growth rates of B16 cells in vitro. Moreover, tumor volume and mitotic index of B16 tumors in vivo did not differ 2 days after implantation when tumors were small enough to be independent of vascularization. After 14 days, tumors from mice fed dietary glycine had 70% fewer arteries (P < 0.05). Furthermore, glycine (0.01–10 mM) inhibited the growth of endothelial cells in vitro in a dose-dependent manner (P < 0.05; IC50 = 0.05 mM). These data support the hypothesis that dietary glycine prevents tumor growth in vivo by inhibiting angiogenesis through mechanisms involving inhibition of endothelial cell proliferation.

4 To whom correspondence should be addressed Email: thurman{at}med.unc.edu


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Integr Cancer TherHome page
M. F. McCarty and K. I. Block
Multifocal Angiostatic Therapy: An Update
Integr Cancer Ther, December 1, 2005; 4(4): 301 - 314.
[Abstract] [PDF]


Home page
Mol Cancer ResHome page
M. D. Wheeler, O. M. Smutney, and R. J. Samulski
Secretion of Extracellular Superoxide Dismutase From Muscle Transduced With Recombinant Adenovirus Inhibits the Growth of B16 Melanomas in Mice
Mol. Cancer Res., October 1, 2003; 1(12): 871 - 881.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
M. Froh, R. G. Thurman, and M. D. Wheeler
Molecular evidence for a glycine-gated chloride channel in macrophages and leukocytes
Am J Physiol Gastrointest Liver Physiol, October 1, 2002; 283(4): G856 - G863.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
X. Li, B. U. Bradford, M. D. Wheeler, S. A. Stimpson, H. M. Pink, T. A. Brodie, J. H. Schwab, and R. G. Thurman
Dietary Glycine Prevents Peptidoglycan Polysaccharide-Induced Reactive Arthritis in the Rat: Role for Glycine-Gated Chloride Channel
Infect. Immun., September 1, 2001; 69(9): 5883 - 5891.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
Z. Liu, W. Ishikawa, X. Huang, H. Tomotake, J. Kayashita, H. Watanabe, and N. Kato
A Buckwheat Protein Product Suppresses 1,2-Dimethylhydrazine-Induced Colon Carcinogenesis in Rats by Reducing Cell Proliferation
J. Nutr., June 1, 2001; 131(6): 1850 - 1853.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. D. Wheeler, M. L. Rose, S. Yamashima, N. Enomoto, V. Seabra, J. Madren, and R. G. Thurman
Dietary glycine blunts lung inflammatory cell influx following acute endotoxin
Am J Physiol Lung Cell Mol Physiol, August 1, 2000; 279(2): L390 - L398.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. L. Rose, R. C. Cattley, C. Dunn, V. Wong, X. Li, and R. G. Thurman
Dietary glycine prevents the development of liver tumors caused by the peroxisome proliferator WY-14,643
Carcinogenesis, November 1, 1999; 20(11): 2075 - 2081.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.